Impact of the changing landscape of induction therapy prior to autologous stem cell transplantation in 540 newly diagnosed myeloma patients: a retrospective real-world study

被引：0

作者：

Song-Yau Wang

Tanja Holzhey

Simone Heyn

Thomas Zehrfeld

Susann Fricke

Franz Albert Hoffmann

Cornelia Becker

Leanthe Braunert

Thomas Edelmann

Inessa Paulenz

Marcus Hitzschke

Franziska Flade

Andreas Schwarzer

Klaus Fenchel

Georg-Nikolaus Franke

Vladan Vucinic

Madlen Jentzsch

Sebastian Schwind

Saskia Hell

Donata Backhaus

Thoralf Lange

Dietger Niederwieser

Markus Scholz

Uwe Platzbecker

Wolfram Pönisch

机构：

[1] Medical Clinic and Policlinic 1,Hematology and Cell Therapy

[2] University Hospital Leipzig,Institute for Medical Informatics, Statistics and Epidemiology (IMISE)

[3] University of Leipzig,undefined

[4] Hospital Torgau,undefined

[5] Hematology Practice,undefined

[6] Hematology Practice,undefined

[7] Hospital Dessau,undefined

[8] Hospital Borna,undefined

[9] Hematology Practice,undefined

[10] Hematology Practice,undefined

[11] Hospital Weißenfels,undefined

[12] University of Leipzig,undefined

来源：

Journal of Cancer Research and Clinical Oncology | 2023年 / 149卷

关键词：

Multiple myeloma; Autologous stem cell transplantation; Bortezomib; Real-world evidence;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：3739 / 3752

页数：13

共 50 条

[31] Impact of Cytogenetic Abnormalities, Induction and Maintenance Regimens on Outcomes After High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma: A Decade-Long Real-World Experience
Thurlapati, Aswani
Wesson, William
Davis, James A.
Gaffney, Kelly J.
Weeda, Erin
Velayati, Arash
Bakos, Jonathan K.
Granger, Katelynn
Smith, Deidra
Maldonado, Andy P.
Herrington, Taylor
Potts, Julia
Hashmi, Hamza
JOURNAL OF HEMATOLOGY, 2023, 12 (06) : 243 - 254
[32] Effect of induction regimen in survival in newly diagnosed multiple myeloma patients receiving consolidation with autologous stem cell transplantation
Garrido, David
von Glassenap, Alana
Pena, Camila
Martinez-Cordero, Humberto
Ramirez-Alvarado, Aline
Tarin-Arzaga, Luz
Schutz, Natalia
Bove, Virginia
Sossa, Claudia
Yantorno, Sebastian
Ochoa, Paola
Orlando, Sergio
Ladines-Castro, Washington
Duarte, Patricio
Remaggi, Guillermina
Shanley, Claudia
Ruiz-Arguelles, Guillermo
Fantl, Dorotea
Riva, Eloisa
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S132 - S133
[33] Bortezomib plus dexamethasone as induction treatment prior to autologous stem cell transplantation in patients with newly diagnosed multiple myeloma: Premilinary results of an IFM phase II study
Harousseau, JL
Attal, M
Coiteux, V
Stoppa, AM
Hulin, C
Benboubker, L
Fuzibet, JG
Renard, M
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 598S - 598S
[34] Lenalidomide Maintenance for Patients with Newly Diagnosed Multiple Myeloma Post Autologous Stem Cell Transplant: A Comparison of Real-World Treatment Outcomes and Costs
Hari, Parameswaran
Ung, Brian
Abouzaid, Safiya
Ni, Quanhong
Parikh, Kejal
Agarwal, Amit
BLOOD, 2017, 130
[35] Deepening Responses after Upfront Autologous Stem Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma in the Era of Novel Agent Induction Therapy
Ebraheem, Mohammad
Kumar, Shaji K.
Dispenzieri, Angela
Jevremovic, Dragan
Buadi, Francis K.
Dingli, David
Cook, Joselle
Lacy, Martha Q.
Hayman, Suzanne R.
Kapoor, Prashant
Leung, Nelson
Fonder, Amie
Hobbs, Miriam
Hwa, Yi Lisa
Muchtar, Eli
Warsame, Rahma
Kourelis, Taxiarchis, V
Russell, Stephen
Binder, Moritz
Lin, Yi
Go, Ronald S.
Siddiqui, Mustaqeem A.
Kyle, Robert A.
Rajkumar, S. Vincent
Gonsalves, Wilson, I
Gertz, Morie A.
TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (11): : 760.e1 - 760.e5
[36] Stem cell mobilization and autologous stem cell transplantation after induction with Bendamustine, Prednisone and Bortezomib (BPV) in newly diagnosed multiple myeloma patients
Wang, S. -Y.
Fricke, S.
Holzhey, T.
Andrea, M.
Holzvogt, M.
Vucinic, V.
Franke, G. -N.
Heyn, S.
Hell, S.
Jentzsch, M.
Scholz, M.
Platzbecker, U.
Merz, M.
Poenisch, W.
ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 178 - 178
[37] EARLY AUTOLOGOUS STEM CELL TRANSPLANTATION IMPROVES SURVIVAL IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS
Cavallo, F.
Spencer, A.
Gay, F.
Hajek, R.
Petrucci, M. T.
Ben Yehuda, D.
Carella, A. M.
Vallone, L. M.
Oliva, S.
Petro, D.
Crippa, C.
Siniscalchi, A.
Gilestro, M.
Pour, L.
Maracci, L.
Pescosta, N.
Liberati, M.
Magarotto, V.
Scudla, V.
Benevolo, G.
Pulini, S.
Caravita, T.
Hardan, I.
Boccadoro, M.
Palumbo, A.
HAEMATOLOGICA, 2014, 99 : 520 - 520
[38] The importance of autologous stem cell transplantation in improving outcomes in newly diagnosed patients with multiple myeloma
Gertz, Morie A.
AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (11) : 2060 - 2062
[39] Upfront autologous stem cell transplantation for newly diagnosed elderly multiple myeloma patients: a prospective multicenter study
Garderet, Laurent
Beohou, Eric
Caillot, Denis
Stoppa, Anne Marie
Touzeau, Cyrille
Chretien, Marie Lorraine
Karlin, Lionel
Moreau, Philippe
Fontan, Jean
Blaise, Didier
Polge, Emmanuelle
Gueye, Mor Seny
Ikhlef, Souhila
Marjanovic, Zora
Labopin, Myriam
Mohty, Mohamad
HAEMATOLOGICA, 2016, 101 (11) : 1390 - 1397
[40] The clinical impact of thalidomide maintenance after autologous stem cell transplantation in patients with newly diagnosed multiple myeloma in real clinical practice of Korea
Lee, Ho Sup
Min, Chang-Ki
Lee, Je-Jung
Kim, Kihyun
Kim, Seok Jin
Yoon, Dok Hyun
Eom, Hyeon-Seok
Lee, Hyewon
Lee, Won Sik
Shin, Ho-Jin
Lee, Ji Hyun
Park, Yong
Jo, Jae-Cheol
Do, Young Rok
Mun, Yeung-Chul
Lee, Mark Hong
ANNALS OF HEMATOLOGY, 2016, 95 (06) : 911 - 919

← 1 2 3 4 5 →